Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation - Summary of stock option activity (Detail)

v3.21.2
Stock-Based Compensation - Summary of stock option activity (Detail) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Jun. 30, 2021
Mar. 31, 2021
Number of options    
Number of options, beginning balance (in shares) 7,988,999  
Number of options, granted (in shares) 431,980  
Number of options, forfeited (in shares) (1,708,790)  
Number of options, ending balance (in shares) 6,712,189 7,988,999
Weighted- Average Exercise Price    
Weighted average exercise price, beginning balance (in dollars per share) $ 16.97  
Weighted average exercise price, granted (in dollars per share) 10.98  
Weighted average exercise price, forfeited (in dollars per share) 27.10  
Weighted average exercise price, ending balance (in dollars per share) $ 14.01 $ 16.97
Additional Disclosures    
Remaining contractual term 8 years 6 months 7 days 9 years 14 days
Aggregate intrinsic value $ 8,142 $ 25,958
Number of options, exercisable (in shares) 2,130,872  
Weighted average exercise price, exercisable (in dollars per share) $ 10.50  
Remaining contractual term, exercisable 8 years  
Aggregate intrinsic value, exercisable $ 4,265